Thyrocare Technologies Dividends and Buybacks
Dividend criteria checks 3/6
Thyrocare Technologies is a dividend paying company with a current yield of 1.85%.
Key information
1.8%
Dividend yield
-0.0004%
Buyback Yield
| Total Shareholder Yield | 1.8% |
| Future Dividend Yield | 2.1% |
| Dividend Growth | 8.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹18.000 |
| Payout ratio | 135% |
Recent dividend and buyback updates
Recent updates
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are
Oct 31
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump
Aug 01Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Jul 26A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)
Jun 12Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: THYROCARE has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: THYROCARE's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
| Thyrocare Technologies Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (THYROCARE) | 1.8% |
| Market Bottom 25% (IN) | 0.2% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Healthcare) | 0.3% |
| Analyst forecast (THYROCARE) (up to 3 years) | 2.1% |
Notable Dividend: THYROCARE's dividend (1.85%) is higher than the bottom 25% of dividend payers in the Indian market (0.24%).
High Dividend: THYROCARE's dividend (1.85%) is in the top 25% of dividend payers in the Indian market (1.08%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (134.7%), THYROCARE's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (57.8%), THYROCARE's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 17:28 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Thyrocare Technologies Limited is covered by 13 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alka Katiyar | Batlivala & Karani Securities India Pvt. Ltd. |
| Rahul Agarwal | CGS International |
| Kameswari V. S. Chavali | FirstCall Research |